30142 Wixom Road
327 articles with Rockwell Medical
Rockwell Medical, Inc. Confirms Medical Resource Acquisition Group’s Director Nominations Are Invalid
Rockwell Medical, Inc. today reiterated that Medical Resource Acquisition Group LLC (MRAG) failed to properly deliver a notice of director nominations under the Company’s Bylaws within the prescribed advance notice period. While MRAG has continued its attempts to
Rockwell Medical, Inc. Announces $35 Million Debt Financing Agreement with Innovatus Capital Partners, LLCFirst $22.5 million tranche funded at closing
Rockwell Medical, Inc. announced that it has entered into a debt financing agreement with an affiliate of Innovatus Capital Partners, LLC to provide the Company with up to $35.0 million in term loans.
Company reports positive adoption trends for Dialysate Triferic® (ferric pyrophosphate citrate), highlighted by 77% increase in clinics under contract
Rockwell Medical, Inc. announced that its Board of Directors has determined that Medical Resource Acquisition Group LLC failed to properly deliver a notice of director nominations under the Company’s Bylaws within the prescribed advance notice period.
Rockwell Medical, Inc. issued the following statement in response to communications publicly disseminated yesterday by an entity named “Medical Resource Acquisition Group LLC”, which purports to be a Rockwell Medical stockholder.
Rockwell Medical, Inc. to Discuss Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020
Rockwell Medical, Inc. announced that the Company will release its 2019 fourth quarter and full year financial results on Thursday, March 12, 2020, after the close of the U.S. financial markets.
Rockwell Medical, Inc. provided a business update and information related to the launch of Dialysate Triferic®.
Rockwell Medical, Inc. announced that Stuart Paul, Chief Executive Officer, will present at the 2020 BIO CEO & Investor Conference
Rockwell Medical, Inc. announced the pricing of its underwritten public offering of 3,191,489 shares of its common stock for gross proceeds of approximately $7.5 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by Rockwell Medical.
Rockwell Medical, Inc. Enters into Exclusive License and Supply Agreements with Sun Pharma for the Rights to Commercialize Triferic® in India- Sizable and growing market opportunity with 120,000+ patients receiving hemodialysis annually –
Rockwell Medical, Inc. announced that it has entered into license and supply agreements with a wholly-owned subsidiary of Sun Pharmaceutical Industries Ltd., for the rights to commercialize Triferic in India.
Dr. Ellison has held leadership positions in both emerging biotechnology and large pharmaceutical companies for more than four decades.
The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.rockwellmed.com, under the “Investors” section.
Rockwell Medical, Inc. announced that Stuart Paul, Chief Executive Officer, will present at the 31st Annual Piper Jaffray Healthcare Conference
Company adds experienced medical executive to management team and leading nephrologists to Medical Advisory Board
Company reports first full quarter of results for Dialysate Triferic, highlighted by greater than 75% conversion rate from Triferic Evaluation Program
Rockwell Medical, Inc. announced that the Company will release its 2019 third quarter financial results on Monday, November 11, 2019, after the close of the U.S. financial markets.
Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an initial focus on end-stage renal disease (ESRD), today announced the appointment of John P. McLaughlin as its Chairman of the Board, effective immediately. Mr. McLaughlin, who joined the Board on September 5, 2019, succeeds Benjamin Wolin, who will remain on the Board of Directors.
Encouraging progress for Triferic® portfolio Conference call at 8:30 am ET on Friday, October 25, 2019
Completes Build-Out of Senior Leadership Team by Stuart Paul
Rockwell Medical, Inc. today announced that Charlie Shiner has been appointed Vice President, Marketing, effective immediately. Mr. Shiner will report to Stuart Paul, President & Chief Executive Officer of the Company.